FPT has launched the MediSight framework to help healthcare and life sciences organizations accelerate digital transformation. The platform provides support for doctors, medical device companies, and pharmaceutical businesses.
MediSight platform includes independent digital workers that use artificial intelligence (AI), healthcare apps, and AI-enabled engineering abilities. The platform helps organizations to automate their clinical, operational, and regulatory processes. In addition, it turns healthcare data into insight.
The development of MediSight has been done based on the FPT FleziPT AI-first ecosystem. Furthermore, it is aligned to CASAN, which is a plan by FPT to implement AI. MediSight combines the use of AI agents, industry-specific accelerators, and intelligence engineering. Thus, healthcare organizations will be able to improve their efficiencies and governance using this platform. MediSight is made up of three main layers, all developed for use in the health sector. First, there is the Healthcare Insight Platform (HIP) that is a cloud-native data infrastructure. The system supports standards like HL7 v2, CDA, FHIR, and DICOM. Additionally, HIP is equipped with capabilities such as data mapping, de-identification, and standardization of clinical terminology.
MediSight AI Framework Strengthens Healthcare Operations and Security
Then there is the MediSight Crew, which features AI-based software agents, digital workers, and healthcare assistants. They help with executing tasks related to administration, clinical activities, and compliance. Additionally, MediSight Verse provides healthcare applications for different purposes, including clinic management, claims management, virtual care, patient engagement, clinical trial, medical imaging, and health analytics.
MediSight AI architecture is another aspect that includes taking care of the security of the healthcare sector. This architecture fulfills the following standards: HIPAA, HITRUST r2, and ISO 27001. Moreover, the said architecture can be implemented on all major clouds. Here, it should be noted that Chu Canh Chieu, VP & CPO Healthcare & Life Sciences at FPT Software, highlighted the importance of AI-driven healthcare innovations.
Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences, FPT Corporation, stated: “The next phase of healthcare innovation demands systems that don’t just store data, but actively reason through it. MediSight helps healthcare organizations reduce manual effort, improve decision-making speed, and scale digital health solutions more efficiently. By fusing autonomous AI agents with specialized clinical applications, we are helping digital health and pharma enterprises eliminate manual friction, reduce time-to-market for medical software, and elevate patient outcomes without compromising on strict regulatory standards.”
The launch enhances the portfolio of FPT in terms of healthcare and life sciences. The company has been supporting global healthcare providers, pharmaceutical firms, and medical device firms for almost two decades. Finally, FPT continues to develop its capability in healthcare technology through certified solutions. The company possesses important standards such as HITRUST r2, HIPAA compliance, ISO 9001, ISO 13485, IEC 62304, HL7, and DICOM.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
